At the top of this once in a generation run the biotechs are the most exhuberant sector. They will be the last to fall. Some of them will succeed but many will fail. ALNY has had a good run but with of minus, yes minus - $371 million they announced a new (additional, not initial) public offering to raise an additional 450 million $. This puts allot of pressure on the stock price as seen in the action in todays chart. Just something to watch for a potential short op. Let's see if in bounces or not. I would imagine it bounces some, if it rolls over then drops thru the bottom of that candle it will get interesting. Whatever it does there will be some trading opportunity...if theres enough vol .
Runaway Gap Down, Moved below and , Dropped below Ich Cloud, Strong Vol decliner, Fell below lower BB, Declining chalkin flow, sell signals,...etc.etc etc If that dosen't come up on peoples radar I don't know what will. Do your due dillgence, there may be an opportunity here. Oh yeah insiders have pulled plenty out of this one. On their behalf they have skills and have formed many alliances with established bio/pharma firms.